Stay updated on Bispecific Antibody MCLA-158 Clinical Trial
Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA site-wide NIH notice was added announcing a transition from “Artificial Intelligence” to “Super Intelligence,” and the footer revision advanced from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error.SummaryDifference1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the usual content with an error message; the additions include a 403 header and a Home link, and the detailed study information is no longer accessible.SummaryDifference21%

- Check44 days agoChange DetectedUpdated the label from 'Find Contact Information' to 'Find contact information', reflecting a capitalization refinement in the page UI. The revision tag changes from v3.6.6 to v3.7.0, indicating a minor version update.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s implementation. This appears to be a behind-the-scenes maintenance update rather than a change to the study content shown on the page.SummaryDifference0.0%

- Check65 days agoChange DetectedAn NIH grant/contract identifier was added to the study's identifiers, linking the trial to U.S. NIH funding.SummaryDifference0.0%

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.